Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 8× · first seen 09-sep-2026 · last seen 07-oct-2026

Gut–Liver–Heart Bile Acid Axis in Aging CAD

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

pubmed observational human-observational
Multivariable-adjusted multi-omics signatures reveal gut microbial functional alterations and metabolic dysregulation in intrinsic capacity decline.
18-aug-2026 novelty 3 per-area 3 strengthens
pubmed review
Bile acids as a "new hormone" in aging-related liver disease.
07-aug-2026 novelty 2 per-area 2 strengthens
pubmed review expert-opinion
Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.
01-aug-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
β-Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota-bile acid-farnesoid X receptor (FXR/NR1H4) axis.
21-jul-2026 novelty 3 per-area 3 strengthens
pubmed preclinical
ASAP3 deficiency alleviates hepatic senescence and correlates with extended healthspan in mice.
10-jul-2026 novelty 3 per-area 2 mentions
pubmed review
Aging-driven metabolic abnormalities remodel intercellular communication through the gut-liver-heart axis and may promote coronary artery disease: the key role of bile acid metabolism.
06-jul-2026 novelty 2 per-area 3 introduces
pubmed observational
Liver- and Immune-Enriched Molecular Signatures Associated With Mortality in Older Adults.
01-jul-2026 novelty 3 per-area 2 mentions
pubmed preclinical animal-model
ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.
08-jun-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18